Quantcast

Latest Pandemics Stories

2014-10-01 08:31:40

The U.S. Department of Health and Human Services will fund up to $12.9 million for the development of Alere's next-generation POC molecular influenza test WALTHAM, Mass., Oct. 1, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostics, today announced that it has entered into a contract with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop diagnostic...

2014-09-26 23:05:37

Will offer training and technical assistance to help Ryan White-funded HIV organizations navigate changing health care landscape Boston, MA (PRWEB) September 26, 2014 The Fenway Institute, AIDS United, and the AIDS Resource Center of Wisconsin have announced a new HRSA-funded training and technical assistance resource for Ryan White-funded AIDS service organizations and community-based organizations. The National Center for Innovation in HIV Care provides free training and technical...

2014-09-23 12:29:35

Powerful Personal Videos Reveal the Impact of HIV And Urge Others to #SpeakOutHIV MENLO PARK, Calif., Sept. 23, 2014 /PRNewswire-USNewswire/ -- Twenty-five young gay men get real about HIV as part of #SpeakOutHIV, a campaign from Greater Than AIDS. The group is encouraging people to break the silence around HIV on social media in the two weeks between National Gay Men's HIV/AIDS Awareness Day (September 27) and National Coming Out Day (October 11). Anchored by a series of powerful...

2014-09-05 08:22:57

BEIJING, Sept. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis Healthcare & Technology Conference, to be held at the Wynn Las Vegas on September 12, 2014. Management will present at 8:00 am PT. Please contact your Aegis representative to schedule a meeting with the Company. About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that...

2014-09-02 08:28:32

BEIJING, Sept. 2, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management will participate in the following investor conferences in September: -- Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt New York on September 9 and 10, 2014. -- Morgan Stanley Asia Pacific Healthcare Day, to be held at the Boston Harbor Hotel on September 11,...

2014-08-27 08:26:54

BEIJING, Aug. 27, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014 Annual General Meeting of Shareholders held on Wednesday, August 27, 2014 in Beijing, PRC. The required quorum, a majority of the common shares outstanding, was voted by proxy. The Company's shareholders approved the following proposals: -- The re-election of Weidong Yin, Yuk Lam Lo, Simon Anderson,...

2014-08-26 16:28:01

New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Influenza H1N1 virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1918. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Influenza H1N1...

2014-08-16 23:00:48

MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas (PRWEB) August 16, 2014 With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing...

flu shot for seniors
2014-08-15 03:13:00

Craig Boerner, Vanderbilt University High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a Vanderbilt-led study published this week in the New England Journal of Medicine (NEJM). The multi-center study enrolled 31,989 participants from 126 research centers in the U.S. and Canada during the 2011-2012 and 2012-2013 influenza seasons in the Northern...

2014-08-12 23:03:06

The North American Swine Feed & Feed Additives Market report defines and segments the swine feed & feed additives market in North America with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/north-america-swine-feed-2493779511.html (PRWEB) August 12, 2014 The North American Swine Feed & Feed Additives Market report defines and segments the swine feed & feed additives market in North America with analysis and forecast of revenue. The swine feed...


Latest Pandemics Reference Libraries

72_f634c1b2916580c60814457a175ea810
2011-04-28 15:06:23

Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related